Related Experiment Videos
Glutathione and drug resistance
C P Schröder1, A K Godwin, P J O'Dwyer
1Department of Medical Oncology, Fox Chase Cancer Center, Philadephia, Pennsylvania, USA.
Cancer Investigation
|January 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity.
bioRxiv : the preprint server for biology·2026
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.
Journal of experimental & clinical cancer research : CR·2023
Distress, problems, referral wish, and supportive health care use in breast cancer survivors beyond the first year after chemotherapy completion.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2019
89Zr-trastuzumab PET supports clinical decision making in breast cancer patients, when HER2 status cannot be determined by standard work up.
European journal of nuclear medicine and molecular imaging·2018
Impact of homologous recombination deficiency biomarkers on outcomes in patients with triple-negative breast cancer treated with adjuvant doxorubicin and cyclophosphamide (SWOG S9313).
Annals of oncology : official journal of the European Society for Medical Oncology·2018
The pharmacogenetic of cyclosporine in Tunisian renal transplantation.
Pharmacogenomics·2026
Disease characteristics of SEPSECS deficiency: an international, retrospective, multicenter cohort study.
Genetics in medicine : official journal of the American College of Medical Genetics·2026